Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer

Saved in:
Bibliographic Details
Published in:Annals of Gastroenterological Surgery
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301677599555587
collection WordPress RSS
FRELIP Feed Integration
container_title Annals of Gastroenterological Surgery
description
discipline_display Surgery
discipline_facet Surgery
format Online Article
RSS Article
genre Journal Article
id rss_article:57640
institution FRELIP
journal_source_facet Annals of Gastroenterological Surgery
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
Surgery
General
Surgery
sub_discipline_display General
sub_discipline_facet General
subject_display Surgery
General
Surgery
Surgery
General
Surgery
subject_facet Surgery
General
Surgery
title To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_auth To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_full To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_fullStr To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_full_unstemmed To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_short To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer
title_sort to evaluate whether pretreatment ca19‐9 and dupan‐2 levels can serve as predictive markers to guide the choice between nat and upfront surgery in pancreatic cancer
topic Surgery
General
Surgery
url https://onlinelibrary.wiley.com/doi/10.1002/ags3.70140?af=R